About the cooper cos. inc. - COO
The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.
COO At a Glance
The Cooper Cos., Inc.
6101 Bollinger Canyon Road
San Ramon, California 94583
| Phone | 1-925-460-3600 | Revenue | 4.09B | |
| Industry | Medical Specialties | Net Income | 374.90M | |
| Sector | Health Technology | 2025 Sales Growth | 5.057% | |
| Fiscal Year-end | 10 / 2026 | Employees | 15,000 | |
| View SEC Filings |
COO Valuation
| P/E Current | 29.696 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 37.295 |
| Price to Sales Ratio | 3.417 |
| Price to Book Ratio | 1.662 |
| Price to Cash Flow Ratio | 17.56 |
| Enterprise Value to EBITDA | 15.06 |
| Enterprise Value to Sales | 4.07 |
| Total Debt to Enterprise Value | 0.167 |
COO Efficiency
| Revenue/Employee | 272,826.667 |
| Income Per Employee | 24,993.333 |
| Receivables Turnover | 4.937 |
| Total Asset Turnover | 0.331 |
COO Liquidity
| Current Ratio | 1.893 |
| Quick Ratio | 1.133 |
| Cash Ratio | 0.099 |
COO Profitability
| Gross Margin | 60.671 |
| Operating Margin | 16.687 |
| Pretax Margin | 13.843 |
| Net Margin | 9.161 |
| Return on Assets | 3.034 |
| Return on Equity | 4.594 |
| Return on Total Capital | 3.401 |
| Return on Invested Capital | 3.439 |
COO Capital Structure
| Total Debt to Total Equity | 33.786 |
| Total Debt to Total Capital | 25.254 |
| Total Debt to Total Assets | 22.458 |
| Long-Term Debt to Equity | 32.747 |
| Long-Term Debt to Total Capital | 24.477 |